Application process

Pre-application

Potential applicants are asked to complete a pre-application form, following an expression of interest in a TACT review. Pre-applications are reviewed by the Chair and Secretariat who assess their suitability to progress to a full application and review. To request a pre-application form or discuss aspects of the process, please contact Cathy Turner.

Full application

Full applications are completed via an online system approximately 3-4 months prior to the review meeting. Completing the application focuses the applicant on a number of important considerations including; scientific rationale, the appropriateness and interpretation of the nonclinical studies performed; safety and toxicology issues; drug distribution and kinetics; feasibility and cost of drug manufacturing and supply; context of project in the clinical development plan and regulatory consideration critical to advancing a compound into clinic.

Support

For academic groups working on treatments or platform technologies for Duchenne muscular dystrophy:   Financial support is available to cover a portion of meeting costs as well as travel and accommodation for eligible individuals or groups. This support is provided via a fund from CureDuchenne. To inquire further, or to request this financial support, please contact Cathy Turner.